John Volpone

Human Resources Officer at CTI BIOPHARMA CORP.

Health Technology

Consumer Services

Profile

John Volpone is currently the Chief of Staff & Executive Vice President at CTI BioPharma Corp.
Previously, he worked as the Director of Business Development at ZymoGenetics, Inc. He completed his undergraduate degree at the University of Washington and holds an MBA from Seattle University.

John Volpone active positions

Companies	Position	Start
CTI BIOPHARMA CORP.	Human Resources Officer	-

All active positions of John Volpone

Former positions of John Volpone

Companies	Position	End
ZymoGenetics, Inc. ZymoGenetics, Inc. Pharmaceuticals: MajorHealth Technology ZymoGenetics, Inc. develops protein based drugs. It focuses on the discovery, development, manufacture, and commercialization of therapeutic proteins for the treatment of human diseases, including homeostasis, inflammatory and autoimmune diseases, cancer, and viral infections. The company was founded by Earl W. Davie, Benjamin D. Hall and Michael Smith in 1981 and is headquartered in Seattle, WA.	Corporate Officer/Principal	-

See the detail of John Volpone's experience

Training of John Volpone

University of Washington	Undergraduate Degree
Seattle University	Masters Business Admin

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of John Volpone's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies	2
CTI BioPharma Corp. CTI BioPharma Corp. Pharmaceuticals: MajorHealth Technology CTI BioPharma Corp. is a biopharmaceutical company, which engages in the development, acquisition, and commercialization of novel targeted therapies for blood-related cancers. It focuses on evaluating pacritinib, its sole product candidate currently in active development, for the treatment of adult patients with myelofibrosis. The company was founded by James A. Bianco, Jack W. Singer, and Louis A. Bianco in September 1991 and is headquartered in Seattle, WA.	Health Technology
ZymoGenetics, Inc. ZymoGenetics, Inc. Pharmaceuticals: MajorHealth Technology ZymoGenetics, Inc. develops protein based drugs. It focuses on the discovery, development, manufacture, and commercialization of therapeutic proteins for the treatment of human diseases, including homeostasis, inflammatory and autoimmune diseases, cancer, and viral infections. The company was founded by Earl W. Davie, Benjamin D. Hall and Michael Smith in 1981 and is headquartered in Seattle, WA.	Health Technology